Bigfoot Biomedical
About:
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Website: http://www.bigfootbiomedical.com
Twitter/X: BigfootBiomed
Top Investors: Abbott, Cormorant Asset Management, Janus Henderson Investors, Smile Group, Taiwania Capital Management Corporation
Description:
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.
$205M
$1M to $10M
Milpitas, California, United States
2014-11-18
info(AT)bigfootbiomedical.com
Bryan Mazlish, Jeffrey Brewer, Jon Brilliant, Lane Desborough
101-250
2022-08-15
Private
© 2024 MyAiNote.com